mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.08 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.08 |